-
Johnson & Johnson's Bold New Chapter Unveiled: A Glimpse into the Future
In a recent announcement, Johnson & Johnson revealed its 2023 performance, showcasing a year of transformative changes and growth.
2024-01-29 11:37 -
TROP2 ADC: A Tale of Divergent Paths for Gilead, Hengrui, and More
The field of Antibody-Drug Conjugates (ADCs) has seen a surge in interest, with Trop2 ADCs gaining significant momentum.
2024-01-29 11:34 -
The Fragility of the Biopharmaceutical Industry: Unraveling the Shadows of Verbal Decoupling
In the realm of geopolitics and global economics, the biopharmaceutical industry has found itself entangled in a web of uncertainty and vulnerability.
2024-01-29 11:32 -
Conquering 'Superbugs': The Rise of Novel Antimicrobial Peptides
"In the constant battle against the threat of "superbugs," the emergence of antibiotic-resistant bacteria has caused growing concern worldwide....
2024-01-29 11:31 -
The Curse of Henlius's 'Mobius Loop': A Tale of Market Disillusionment
Henlius, a leading innovative pharmaceutical company in China, has experienced a remarkable turnaround in recent years.
2024-01-29 11:30 -
Johnson & Johnson Unveils Ambitious Restructuring Plan for its Medical Device Business
Johnson & Johnson, a leading healthcare company, recently announced its latest plan for a major overhaul of its medical device business.
2024-01-26 11:25 -
Pharmaron Collaborates with Celltrion to Secure Major Overseas ADC Contract Just Two Months after Go...
Pharmaron, a prominent player in the pharmaceutical industry, has made significant strides in the development and production of antibody-drug conjugat...
2024-01-26 11:24 -
Biotech's Revenue Soars Tenfold with Only Two Products
In the midst of the pharmaceutical industry's challenging landscape, one Biotech company has managed to defy the odds and achieve extraordinary succes...
2024-01-26 11:19 -
CIETAC Arbitration Tribunal Rejects All Claims by Hengrui Pharmaceutical in the Pralatrexate BD Disp...
In a recent development, the China International Economic and Trade Arbitration Commission (CIETAC) arbitration tribunal delivered its final verdict o...
2024-01-26 11:13 -
Breakthrough in Treating Severe Generalized Myasthenia Gravis: Receiving IND Approval for Igiloncel ...
Reindeer Biotech, a leading biopharmaceutical company dedicated to cell-based innovative drug research, production, and sales, has achieved a signific...
2024-01-26 11:11
Hot News
- SABIC Shuts Down 865,000-Ton U... Jul 02, 2025
- ExxonMobil Launches $10 Billio... Jul 17, 2025
- Global MDI/TDI Plants Enter Pe... Jul 23, 2025
- Europe Faces Unprecedented Pet... Jul 23, 2025
- UBE Corporation Accelerates Ch... Jul 02, 2025
Related Products
Related Producers
